Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Gene Essentiality Profiling Reveals Gene Networks and Synthetic Lethal Interactions with Oncogenic Ras.

Wang T, Yu H, Hughes NW, Liu B, Kendirli A, Klein K, Chen WW, Lander ES, Sabatini DM.

Cell. 2017 Feb 23;168(5):890-903.e15. doi: 10.1016/j.cell.2017.01.013. Epub 2017 Feb 2.

PMID:
28162770
2.

Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.

Rosenbluh J, Mercer J, Shrestha Y, Oliver R, Tamayo P, Doench JG, Tirosh I, Piccioni F, Hartenian E, Horn H, Fagbami L, Root DE, Jaffe J, Lage K, Boehm JS, Hahn WC.

Cell Syst. 2016 Sep 28;3(3):302-316.e4. doi: 10.1016/j.cels.2016.09.001.

PMID:
27684187
3.

Characterizing genomic alterations in cancer by complementary functional associations.

Kim JW, Botvinnik OB, Abudayyeh O, Birger C, Rosenbluh J, Shrestha Y, Abazeed ME, Hammerman PS, DiCara D, Konieczkowski DJ, Johannessen CM, Liberzon A, Alizad-Rahvar AR, Alexe G, Aguirre A, Ghandi M, Greulich H, Vazquez F, Weir BA, Van Allen EM, Tsherniak A, Shao DD, Zack TI, Noble M, Getz G, Beroukhim R, Garraway LA, Ardakani M, Romualdi C, Sales G, Barbie DA, Boehm JS, Hahn WC, Mesirov JP, Tamayo P.

Nat Biotechnol. 2016 May;34(5):539-46. doi: 10.1038/nbt.3527. Epub 2016 Apr 18.

4.

Oncogenic Signaling Adaptor Proteins.

Luo LY, Hahn WC.

J Genet Genomics. 2015 Oct 20;42(10):521-9. doi: 10.1016/j.jgg.2015.09.001. Epub 2015 Sep 12. Review.

5.

DINGO: differential network analysis in genomics.

Ha MJ, Baladandayuthapani V, Do KA.

Bioinformatics. 2015 Nov 1;31(21):3413-20. doi: 10.1093/bioinformatics/btv406. Epub 2015 Jul 6.

6.
7.

RAS Synthetic Lethal Screens Revisited: Still Seeking the Elusive Prize?

Downward J.

Clin Cancer Res. 2015 Apr 15;21(8):1802-9. doi: 10.1158/1078-0432.CCR-14-2180. Review.

8.

Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma.

Hoshida Y, Fuchs BC, Bardeesy N, Baumert TF, Chung RT.

J Hepatol. 2014 Nov;61(1 Suppl):S79-90. doi: 10.1016/j.jhep.2014.07.010. Epub 2014 Nov 3. Review.

9.

Polygenic in vivo validation of cancer mutations using transposons.

Chew SK, Lu D, Campos LS, Scott KL, Saci A, Wang J, Collinson A, Raine K, Hinton J, Teague JW, Jones D, Menzies A, Butler AP, Gamble J, O'Meara S, McLaren S, Chin L, Liu P, Futreal PA.

Genome Biol. 2014 Sep 27;15(9):455. doi: 10.1186/s13059-014-0455-6.

10.

Abnormal promoter methylation of multiple tumor suppressor genes in human bronchial epithelial malignant cells.

Liu C, Li P, Gao D, Zhou P, Shao Y, Zhang Q, Li W.

Biomed Rep. 2014 Jul;2(4):525-528. Epub 2014 Apr 11.

11.

Requirement for CDK6 in MLL-rearranged acute myeloid leukemia.

Placke T, Faber K, Nonami A, Putwain SL, Salih HR, Heidel FH, Krämer A, Root DE, Barbie DA, Krivtsov AV, Armstrong SA, Hahn WC, Huntly BJ, Sykes SM, Milsom MD, Scholl C, Fröhling S.

Blood. 2014 Jul 3;124(1):13-23. doi: 10.1182/blood-2014-02-558114. Epub 2014 Apr 24.

12.

Non-synonymous variations in cancer and their effects on the human proteome: workflow for NGS data biocuration and proteome-wide analysis of TCGA data.

Cole C, Krampis K, Karagiannis K, Almeida JS, Faison WJ, Motwani M, Wan Q, Golikov A, Pan Y, Simonyan V, Mazumder R.

BMC Bioinformatics. 2014 Jan 27;15:28. doi: 10.1186/1471-2105-15-28.

13.

Integration of cancer genomics with treatment selection: from the genome to predictive biomarkers.

Ow TJ, Sandulache VC, Skinner HD, Myers JN.

Cancer. 2013 Nov 15;119(22):3914-28. doi: 10.1002/cncr.28304. Epub 2013 Aug 20. Review.

14.

Alteration of human blood cell transcriptome in uremia.

Scherer A, Günther OP, Balshaw RF, Hollander Z, Wilson-McManus J, Ng R, McMaster WR, McManus BM, Keown PA.

BMC Med Genomics. 2013 Jun 28;6:23. doi: 10.1186/1755-8794-6-23.

15.

RSK3/4 mediate resistance to PI3K pathway inhibitors in breast cancer.

Serra V, Eichhorn PJ, García-García C, Ibrahim YH, Prudkin L, Sánchez G, Rodríguez O, Antón P, Parra JL, Marlow S, Scaltriti M, Pérez-Garcia J, Prat A, Arribas J, Hahn WC, Kim SY, Baselga J.

J Clin Invest. 2013 Jun;123(6):2551-63. doi: 10.1172/JCI66343. Epub 2013 May 1. Erratum in: J Clin Invest. 2014 Mar 3;124(3):1418.

16.

Integrative analysis of somatic mutations altering microRNA targeting in cancer genomes.

Ziebarth JD, Bhattacharya A, Cui Y.

PLoS One. 2012;7(10):e47137. doi: 10.1371/journal.pone.0047137. Epub 2012 Oct 16.

17.

The non-coding oncogene: a case of missing DNA evidence?

Shahrouki P, Larsson E.

Front Genet. 2012 Sep 12;3:170. doi: 10.3389/fgene.2012.00170. eCollection 2012.

18.

Pacific biosciences sequencing technology for genotyping and variation discovery in human data.

Carneiro MO, Russ C, Ross MG, Gabriel SB, Nusbaum C, DePristo MA.

BMC Genomics. 2012 Aug 5;13:375. doi: 10.1186/1471-2164-13-375.

19.

Toward personalized cancer nanomedicine - past, present, and future.

Stegh AH.

Integr Biol (Camb). 2013 Jan;5(1):48-65. doi: 10.1039/c2ib20104f.

20.

Identifying gnostic predictors of the vaccine response.

Haining WN, Pulendran B.

Curr Opin Immunol. 2012 Jun;24(3):332-6. doi: 10.1016/j.coi.2012.03.010. Epub 2012 May 26. Review.

Supplemental Content

Support Center